Commerce Bank Abb Vie Inc. Transaction History

Commerce Bank

$15.3 Billion
Q2 2024

A detailed history of Commerce Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Commerce Bank holds 528,858 shares of ABBV stock, worth $102 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

528,858

Previous 519,647 1.77%

Holding current value

$102 Million

Previous $94.6 Million 4.14%

% of portfolio

0.59%

Previous 0.63%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $1.43 Million - $1.66 Million	9,211 Added 1.77%	528,858 $90.7 Million
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $4.08 Million - $4.64 Million	25,500 Added 5.16%	519,647 $94.6 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $660,204 - $743,546	-4,798 Reduced 0.96%	494,147 $76.6 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $2.03 Million - $2.35 Million	-15,218 Reduced 2.96%	498,945 $74.4 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $2.81 Million - $3.49 Million	-21,194 Reduced 3.96%	514,163 $69.3 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $521,463 - $600,543	-3,606 Reduced 0.67%	535,357 $85.3 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $8.15 Million - $9.78 Million	-58,933 Reduced 9.86%	538,963 $87.2 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $352,972 - $404,835	-2,630 Reduced 0.44%	597,896 $80.2 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $788,837 - $1 Million	5,732 Added 0.96%	600,526 $92 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $32,995 - $40,937	-250 Reduced 0.04%	594,794 $96.4 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $697,113 - $882,049	-6,489 Reduced 1.08%	595,044 $80.6 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $6.56 Million - $7.45 Million	61,688 Added 11.43%	601,533 $64.9 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $1.62 Million - $1.81 Million	15,416 Added 2.94%	539,845 $60.8 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $6.31 Million - $6.95 Million	61,669 Added 13.33%	524,429 $56.8 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $5.91 Million - $7.98 Million	73,432 Added 18.86%	462,760 $49.6 Million
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $756,179 - $887,505	-8,802 Reduced 2.21%	389,328 $34.1 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $5.69 Million - $7.61 Million	77,524 Added 24.18%	398,130 $39.1 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $723,948 - $1.1 Million	11,224 Added 3.63%	320,606 $24.4 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $313,404 - $392,136	-4,345 Reduced 1.38%	309,382 $27.4 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $468,949 - $563,811	7,446 Added 2.43%	313,727 $23.8 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $131,662 - $168,295	-2,004 Reduced 0.65%	306,281 $22.3 Million
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $207,815 - $244,588	-2,694 Reduced 0.87%	308,285 $24.8 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $745,958 - $919,967	-9,582 Reduced 2.99%	310,979 $28.7 Million
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $110,515 - $122,858	-1,243 Reduced 0.39%	320,561 $30.3 Million
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $37,707 - $44,616	420 Added 0.13%	321,804 $29.8 Million
Q1 2018 May 03, 2018	BUY	$92.01 - $123.21 $51,433 - $68,874	559 Added 0.17%	321,384 $30.4 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $4.13 Million - $4.53 Million	-46,163 Reduced 12.58%	320,825 $31 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $1.03 Million - $1.32 Million	14,773 Added 4.19%	366,988 $26.6 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $24.6 Million - $31.4 Million	352,215	352,215 $31.3 Million

Others Institutions Holding ABBV

# of Institutions

3,693

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account